These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11516778)
1. Manipulating the immune system: humoral versus cell-mediated immunity. McNeela EA; Mills KH Adv Drug Deliv Rev; 2001 Sep; 51(1-3):43-54. PubMed ID: 11516778 [TBL] [Abstract][Full Text] [Related]
2. Immunomodulators and delivery systems for vaccination by mucosal routes. Ryan EJ; Daly LM; Mills KH Trends Biotechnol; 2001 Aug; 19(8):293-304. PubMed ID: 11451471 [TBL] [Abstract][Full Text] [Related]
3. Delivery systems and adjuvants for vaccination against HIV. Velin D; Kraehenbuhl JP EXS; 2000; 89():227-37. PubMed ID: 10997292 [TBL] [Abstract][Full Text] [Related]
4. Recent developments in adjuvants for vaccines against infectious diseases. O'Hagan DT; MacKichan ML; Singh M Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599 [TBL] [Abstract][Full Text] [Related]
5. Microparticles as vaccine adjuvants and delivery systems. O'Hagan DT; Singh M Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577 [TBL] [Abstract][Full Text] [Related]
6. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible? Marasini N; Kaminskas LM Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems. Wang N; Qian R; Liu T; Wu T; Wang T Crit Rev Ther Drug Carrier Syst; 2019; 36(5):449-484. PubMed ID: 32421952 [TBL] [Abstract][Full Text] [Related]
8. Mucosal delivery of vaccine antigens and its advantages in pediatrics. De Magistris MT Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335 [TBL] [Abstract][Full Text] [Related]
9. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases. Marciani DJ Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131 [TBL] [Abstract][Full Text] [Related]
10. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines. Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120 [TBL] [Abstract][Full Text] [Related]
12. Cytokines as adjuvants for the induction of mucosal immunity. Boyaka PN; McGhee JR Adv Drug Deliv Rev; 2001 Sep; 51(1-3):71-9. PubMed ID: 11516780 [TBL] [Abstract][Full Text] [Related]
15. ISCOMATRIX adjuvant: a potent inducer of humoral and cellular immune responses. Pearse MJ; Drane D Vaccine; 2004 Jun; 22(19):2391-5. PubMed ID: 15193400 [TBL] [Abstract][Full Text] [Related]
16. Generation of improved mucosal vaccines by induction of innate immunity. Lavelle EC Cell Mol Life Sci; 2005 Dec; 62(23):2750-70. PubMed ID: 16237500 [TBL] [Abstract][Full Text] [Related]
17. New generation of mucosal adjuvants for the induction of protective immunity. Yuki Y; Kiyono H Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340 [TBL] [Abstract][Full Text] [Related]
18. Controlled delivery of antigens and adjuvants in vaccine development. Zhao Z; Leong KW J Pharm Sci; 1996 Dec; 85(12):1261-70. PubMed ID: 8961136 [TBL] [Abstract][Full Text] [Related]
19. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles. Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573 [TBL] [Abstract][Full Text] [Related]
20. Jump-starting the immune system: prime-boosting comes of age. Woodland DL Trends Immunol; 2004 Feb; 25(2):98-104. PubMed ID: 15102369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]